Shree Hari Chemicals Export Ltd (524336)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Shree Hari's revenue was ₹54.9 Cr (+125.8% year on year, +33.2% on the previous quarter), and net profit ₹5.9 Cr (against a loss a year earlier); the operating margin was 15.4%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹54.9 | +125.8% | +33.2% |
| Operating profit | ₹8.5 | from loss | — |
| Net profit | ₹5.9 | from loss | +469.4% |
| EPS (₹) | 9.41 | from loss | +400.5% |
| Operating margin | 15.4% | — | — |
📢 Recent Corporate Announcements
Shree Hari Chemicals Export Ltd announced shareholder approval at its AGM held on September 24, 2026, to alter the Main Objects Clause of its Memorandum of Association (MOA). The company is expanding its scope beyond chemicals by adding three new business activities: heavy machinery and crane manufacturing/leasing, investment and dealing in securities/land, and infrastructure development/EPC projects. This represents a substantial strategic diversification away from its core commodity chemical operations (which generated TTM revenue of ₹215 Cr). No capital commitments or specific project outlays were disclosed in the filing.
- Shareholder approval granted at the AGM on September 24, 2026, for MOA alteration.
- Incorporated new sub-clause (9) to manufacture, trade, hire, and service heavy machinery, cranes, defense vehicles, and equipment.
- Incorporated sub-clause (10) permitting investments and dealings in land, shares, stocks, bonds, and derivatives.
- Incorporated sub-clause (11) enabling infrastructure projects, civil works, and EPC/turnkey contracts across sectors like roads, power, and ports.
- Meeting commenced at 12:30 PM and concluded at 12:51 PM IST.
Shree Hari Chemicals Export Ltd's Board has approved an amendment to the Object Clause of its Memorandum of Association (MoA), subject to shareholder approval. The company is adding three new main object clauses covering heavy machinery and defence equipment trading/servicing, investments in securities and land, and large-scale infrastructure/EPC development contracts. This marks an enabling step to diversify significantly beyond its core commodity chemicals business (which reported Q1 FY27 revenue of Rs 54.91 Cr).
- Board approved addition of 3 new sub-clauses (9, 10, 11) to the Main Objects Clause on August 25, 2026
- Clause (9) enables manufacturing, trading, and leasing of cranes, heavy machinery, and defence vehicles
- Clause (10) authorizes investments and dealings in land, securities, derivatives, and government bonds
- Clause (11) covers civil EPC, BOT/BOOT infrastructure projects spanning roads, railways, ports, and power
Shree Hari Chemicals Export Ltd's Board has approved the re-appointment of Shri Bankesh Chandra Agrawal as Chairman & Managing Director for a 3-year term starting November 11, 2026. The Board also renewed the 3-year tenures of Whole Time Directors Shri Sarthak Agarwal and Shri Nihit Agrawal effective November 11, 2026. Additionally, Independent Director Mr. Shri Ram Gupta was re-appointed for a second 5-year term from September 29, 2026, and Shri Amrut Urkude was appointed as an Additional Independent Director for a 5-year term from August 25, 2026. All appointments remain subject to shareholder approval.
- Re-appointment of Bankesh Chandra Agrawal as CMD for 3 years effective November 11, 2026
- Re-appointment of Sarthak Agarwal and Nihit Agrawal as Whole Time Directors for 3 years from November 11, 2026
- Re-appointment of Shri Ram Gupta as Independent Director for a second 5-year term from September 29, 2026
- Appointment of Amrut Urkude as Additional Independent Director for 5 years effective August 25, 2026
Shree Hari Chemicals Export Ltd's Board has approved the issuance of 22,85,000 convertible warrants at Rs 176.10 each on a preferential basis to promoter group members, aggregating to Rs 40.24 crore. The issue price represents a premium over the current market price of Rs 152.20. An upfront payment of 25% will be received upon subscription, with the remaining 75% payable within 18 months upon warrant exercise. The total fundraise of Rs 40.24 crore is significant compared to the company's existing net worth of Rs 45 crore.
- Approved issue of 22,85,000 convertible warrants aggregating to Rs 40,23,88,500 (Rs 40.24 Cr)
- Issue price set at Rs 176.10 per share (face value Rs 10 plus premium of Rs 166.10)
- Allotted entirely to 4 promoter group members (Nihit Agarwal, Priyamvada Agarwal, Avanticka Agarwal, and Smradhi Agarwal)
- 25% payable on allotment and remaining 75% payable upon conversion within 18 months
Shree Hari Chemicals' board approved the issuance of 22,85,000 convertible warrants at Rs 176.10 each on a preferential basis to promoters, aggregating to Rs 40.24 crore. The issue price of Rs 176.10 is at a premium to the current market price of Rs 152.20, and the fundraise represents ~89% of the company's net worth (Rs 45 crore). Proceeds will support capacity expansion and working capital in its wholly-owned subsidiary, Shakambhari Dyechem Private Limited. The board also approved altering its MOA object clause to enter infrastructure, EPC, and heavy machinery businesses, subject to shareholder approval at the AGM on September 24, 2026.
- Preferential issuance of 22,85,000 convertible warrants at Rs 176.10 each, raising Rs 40,23,88,500 entirely from promoters.
- Issue price of Rs 176.10 is at a premium to the current trading price of Rs 152.20.
- Fundraise amount of Rs 40.24 crore represents ~89% of existing Net Worth of Rs 45 crore.
- 25% subscription payable upfront with balance 75% within an 18-month conversion window.
- 39th Annual General Meeting scheduled for September 24, 2026 to seek shareholder approval.
Shree Hari Chemicals Export Ltd has announced a Board of Directors meeting scheduled for Tuesday, August 25, 2026, to consider and approve the issuance of warrants on a preferential basis. The Board will also consider convening the 39th Annual General Meeting (AGM) to seek shareholder approval for the proposed fundraise. Consequently, the trading window for dealing in company securities is closed from August 19, 2026, to August 27, 2026. Details regarding the pricing, issue size, and target allottees will be known following the board outcome.
- Board meeting scheduled for August 25, 2026, to evaluate preferential warrant issuance
- Company to convene its 39th Annual General Meeting for shareholder approval
- Trading window closed from August 19, 2026, to August 27, 2026
- Issue size, pricing, and allottee details are currently not disclosed
Shree Hari Chemicals Export Ltd has submitted its statement of NIL deviation for the quarter ended June 30, 2026, regarding the utilization of funds raised through a preferential issue. The company raised a total of Rs 14.75 crore in multiple tranches between November 2024 and July 2025. Management confirmed that these proceeds have now been fully utilized as per the objects approved in the September 2024 AGM. This fundraise represents approximately 15.4% of the company's current market capitalization of Rs 96 crore.
- Total amount raised through preferential issues was Rs 14,74,59,820 (approx. Rs 14.75 Cr).
- Funds were raised across five dates between November 12, 2024, and July 11, 2025.
- The company reported zero (NIL) deviation or variation in the use of these funds.
- Proceeds have been confirmed as fully utilized as of the June 30, 2026, reporting period.
- The fundraise amount is significant, representing ~32.8% of the company's net worth of Rs 45 Cr.
Shree Hari Chemicals Export Ltd reported a strong turnaround in Q1 FY27, with consolidated revenue growing 125.8% YoY to Rs 54.91 Cr. The company posted a net profit of Rs 5.92 Cr, a significant recovery from a net loss of Rs 1.67 Cr in the same quarter last year. Remarkably, this single quarter's profit exceeds the entire TTM PAT of Rs 4 Cr. The equity base also expanded following the conversion of 7.75 lakh CCDs into equity shares in April 2026.
- Consolidated Revenue from operations surged 125.8% YoY to Rs 54.91 Cr from Rs 24.32 Cr.
- Net Profit turned positive at Rs 5.92 Cr compared to a loss of Rs 1.67 Cr in Q1 FY26.
- Quarterly EPS reached Rs 9.41, which is higher than the full-year FY26 EPS of Rs 8.23.
- Equity share capital increased to Rs 6.31 Cr following the conversion of 7,74,946 CCDs on April 03, 2026.
- Operating expenses rose to Rs 47.69 Cr, with 'Other Expenses' increasing to Rs 10.75 Cr from Rs 7.71 Cr YoY.
Shree Hari Chemicals reported a significant turnaround in Q1 FY27, with net profit reaching ₹5.89 Cr compared to a loss of ₹1.66 Cr in the same quarter last year. Revenue from operations surged 125.8% YoY to ₹54.91 Cr, driven by improved operational scale. Notably, the quarterly profit of ₹5.89 Cr has already exceeded the company's total TTM PAT of ₹4 Cr. The company also confirmed the full utilization of ₹14.75 Cr raised through preferential issues with zero deviation.
- Revenue from operations increased to ₹54.91 Cr in Q1 FY27 from ₹24.32 Cr in Q1 FY26.
- Net profit turned positive at ₹5.89 Cr against a loss of ₹1.66 Cr in the previous year's corresponding quarter.
- Earnings Per Share (EPS) for the quarter stood at ₹9.36, a sharp recovery from negative ₹3.37 YoY.
- Allotted 7,74,946 equity shares on April 03, 2026, following the conversion of Zero Coupon Compulsorily Convertible Debentures (CCDs).
- Fully utilized ₹14.75 Cr raised via preferential issues between November 2024 and July 2025 for stated business objects.
Shree Hari Chemicals Export Ltd has responded to a BSE query regarding recent significant price movements in its stock. The company officially stated that it has no undisclosed price-sensitive information or events that could impact its operations or financial performance. This clarification comes as the stock has delivered a 51.8% return over the last six months, despite a relatively low TTM operating margin of 3.7%. Investors should note that promoter holding has increased significantly from 54.25% in September 2025 to 64.26% by April 2026.
- BSE issued a clarification request on August 07, 2026, regarding recent price volatility.
- Company confirms no undisclosed material events or information exist as of August 07, 2026.
- Stock has experienced a 51.8% price return over the trailing 6-month period.
- Promoter holding increased by 10.01% between September 2025 and April 2026.
- TTM Revenue stands at Rs 185 Cr with a thin Net Profit of Rs 4 Cr.
Shree Hari Chemicals Export Ltd has scheduled a board meeting on August 14, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company is coming off a volatile FY26 where revenue reached Rs 184 Cr but operating margins remained thin at 4.0%. Investors will watch for year-on-year improvement, as the corresponding quarter last year (Jun 2025) saw a net loss of Rs 1.66 Cr. The trading window for insiders will remain closed until August 17, 2026.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
- Trading window for insiders to re-open on August 17, 2026.
- Company reported a TTM revenue of Rs 185 Cr against a small market cap of Rs 86 Cr.
- Previous year's corresponding quarter (Jun 2025) recorded a net loss of Rs 1.66 Cr.
Shree Hari Chemicals Export Ltd has responded to a BSE surveillance query regarding significant movement in its stock price. The company clarified that there are no undisclosed events, information, or price-sensitive developments that have a bearing on its operations or performance. This response follows a notable 32.9% price appreciation in the stock over the last three months. The filing is a standard regulatory procedure to ensure market transparency.
- BSE issued a clarification request on July 16, 2026, regarding significant price movement
- Company responded on July 17, 2026, stating no undisclosed price-sensitive information exists
- Stock has delivered a 32.9% return over the preceding 3-month period
- Management confirms all material events have been previously disclosed to the exchange
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
